LBA2_PR: Osimertinib (AZD9291) in pre-treated pts with T790M-positive advanced NSCLC: updated Phase 1 (P1) and pooled Phase 2 (P2) results

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Journal of Thoracic Oncology

Abbreviated Title: Journal of Thoracic Oncology

Publisher: Elsevier BV

ISSN (Print): 15560864

Publication date Created: April 2016

Publication date (Print): April 2016

Volume: 11

Issue: 4

Pages: S152-S153

Article

DOI: 10.1016/S1556-0864(16)30325-2

SO-VID: 5a6b4e0a-4733-4c23-807f-da5977ab1ef4

License:

http://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_

Cited by 21

See all cited by